A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV. The invention is intended to include all isotopically labeled analogs of the compounds of the invention. Isotopes include those atoms having the same atomic number but different mass.La présente invention concerne une catégorie de composés qui inhibent le virus de lhépatite C (VHC), des compositions contenant ledit composé, et des méthodes dutilisation de ladite composition dans le traitement dindividus infectés par le VHC.